Nina V. Kraguljac
Neuroscience · The Ohio State University
Publications
134
Citations
3,904
Est. group size
~2
Recurring co-author estimate
Active years
32
Publishing since 1995
Nina V. Kraguljac studies the brain in early-stage, medication-free psychosis and schizophrenia using MRI-based techniques, including brain chemistry measures (like glutamate and GABA), brain connectivity mapping, and structural imaging of regions such as the hippocampus. Her work often tracks how these brain measures change over time and with antipsychotic treatment, and increasingly involves normative modeling approaches that compare individual patients against population brain-development trends. This research is aimed at identifying biological markers that could help understand or predict outcomes in psychotic disorders.
Publication output has been fairly steady over the last decade, averaging roughly 10 papers per year with some year-to-year fluctuation but no clear long-term increase or decline.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Charting the velocity of brain growth and development
Europe PMC (PubMed Central) · 2026
- Charting the velocity of brain growth and development
arXiv (Cornell University) · 2026
- A Systematic Review of the Magnetic Resonance Imaging Literature Investigating the Deficit Syndrome in Schizophrenia
Schizophrenia Bulletin Open · 2026
- MDMA and MDMA-Assisted Therapy
American Journal of Psychiatry · 2025
- Lifespan Normative Models of White Matter Fractional Anisotropy: Applications to Early Psychosis
Biological Psychiatry · 2025
- Psilocybin: From Psychiatric Pariah to Perceived Panacea
American Journal of Psychiatry · 2025
- Cortical myelin mapping in antipsychotic medication-naïve, first-episode psychosis patients
Neuropsychopharmacology · 2025
- Post-roe psychiatry: part I − A systematic review and multilevel meta-analysis investigating the impact of unwanted pregnancy and denied abortion on mental health
Personalized Medicine in Psychiatry · 2025
- A Longitudinal Assessment of Anterior Cingulate Cortex Gamma-aminobutyric Acid in Antipsychotic Medication-naïve First Episode Psychosis Patients
Schizophrenia Bulletin · 2025
- Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naïve first-episode psychosis patients
Psychological Medicine · 2025
- 34. A Longitudinal Analysis of Hippocampal Glutamate and Volumes Loss in Medication Naïve First Episode Psychosis Patients
Biological Psychiatry · 2025
- Evaluating the Machine Learning Literature: A Primer and User’s Guide for Psychiatrists
FOCUS The Journal of Lifelong Learning in Psychiatry · 2025
- Replication of biological subgroups using resting-state functional connectivity normative modeling in patients with PSD
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025
- Subcortical brain abnormalities and cognitive function in individuals with psychosis and their unaffected relatives: A normative modeling approach
Schizophrenia Research · 2025
- Efficacy of Omega-3 Fatty Acids in – A Systematic Review and Metaanalysis
Psychopharmacology Bulletin · 2025
- Schizophrenia Bulletin×22
- Biological Psychiatry×16
- American Journal of Psychiatry×8
- Biological Psychiatry Cognitive Neuroscience and Neuroimaging×6
- Schizophrenia×5
- Jessica A. Turner
Neuroscience · The Ohio State University
- Krista Wisner
Neuroscience · Indiana University
- Damon Pham
Neuroscience · Indiana University
- Ivy F. Tso
Neuroscience · The Ohio State University
- Lindsey Kitchell
Neuroscience · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile